Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
JCO Oncol Pract ; 16(10): e1112-e1119, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32539649

RESUMO

PURPOSE: Psychological health at work for care providers is an important issue, because they are directly involved in quality of patient care. Managerial and organizational determinants have been found to be indicators of psychological health at work. The main objective of this study was to explore the relationships between the psychological health at work of pediatric oncology care workers with managerial and organizational determinants and with quality of care. MATERIALS AND METHODS: We performed regression analysis between psychological health at work (quality of work life [QWL], job satisfaction, and so on), managerial determinants (transformational leadership, perceived autonomy support), organizational determinants (organizational support, organizational justice, and participatory approach), and perceived quality of care. RESULTS: Participants were 510 health care professionals working in French pediatric oncology centers. No significant differences in the psychological health at work of the participants were found based on age, sex, length of employment, or professional discipline. In simple regression, significant associations were found between psychological health at work with all managerial and organizational determinants. In multiple regression, a significant link was found between QWL and perceived organizational support (ß = .21; P < .001), organizational justice (ß = .20, P < .001), and overall participatory approach (ß = .10; P < .02). Job satisfaction was also related to perceived organizational support (ß = .16; P < .01). Finally, perceived quality of care was linked to QWL (ß = .15; P < .01) and job satisfaction (ß = .30; P < .001). CONCLUSION: These results emphasize the importance of the role of managers and the organization in psychological health at work of health care providers and also in the quality of patient care.


Assuntos
Oncologia/organização & administração , Cultura Organizacional , Pediatria/organização & administração , Qualidade da Assistência à Saúde , Criança , Humanos , Satisfação no Emprego , Neoplasias , Justiça Social
2.
Health Qual Life Outcomes ; 11: 193, 2013 Nov 13.
Artigo em Inglês | MEDLINE | ID: mdl-24225051

RESUMO

BACKGROUND: Immune thrombocytopenia (ITP) is a childhood disorder that is often life-altering for children and their parents. Health related quality of life (HRQL) has never been chronologically monitored in children with ITP. We initiated a prospective study to assess HRQL from diagnosis to six months and define factors that influence this outcome in children with ITP. METHODS: 73 children with acute ITP aged from 2 to 18 years were prospectively enrolled in the study. According to the presence of bleeding, they were or were not given a 4-day course of corticosteroid treatment. The PedsQL™ 4.0 Generic Core Scale was completed by children and parents upon their inclusion in the study and 6 months after diagnosis. RESULTS: Over the six month period, quality of life improved in terms of their global, physical and psychosocial well-being for 54.5%, 35.6% and 36.2% of patients respectively. This improvement is clinically relevant compared to scores at diagnosis, corresponding at least to a minimal clinically important difference (MCID). Factors such as sex, age, platelet count, bleeding scores, bone marrow aspiration and persistence of ITP at 6 months were not significantly associated with HRQL scores. However, preceding viral infection was identified to have an impact on HRQL. CONCLUSIONS: This first longitudinal study assessing HRQL in children with ITP reveals a global improvement in PedSQL™ 4.0. However, these results should be considered with caution since our data also confirm that self-report HRQL scores are not influenced by any analyzed biologic or clinical parameters. Others tools, such as Kids' ITP Tools, would probably be required to assess the HRQL of this population. TRIAL REGISTRATION: Trial registration clinical trials.gov Identifier: NCT00331357.


Assuntos
Nível de Saúde , Qualidade de Vida/psicologia , Inquéritos e Questionários/normas , Trombocitopenia/imunologia , Trombocitopenia/psicologia , Adolescente , Doenças Autoimunes/psicologia , Criança , Pré-Escolar , Feminino , França , Humanos , Masculino , Estudos Prospectivos
3.
J Pediatr Hematol Oncol ; 31(5): 362-6, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19415021

RESUMO

The authors report a case of nasal-type natural killer/T (NK/T)-cell lymphoma in a 15 years old girl, with rapid fatal evolution. NK/T proliferations are very rare and only a few cases have been described in children, most of them NK/T-cell lymphoma or leukemia, but not nasal-type NK/T-cell lymphoma. Clinical and biologic characteristics of these diseases are discussed with focus on their aggressivity and poor response to conventional chemotherapy.


Assuntos
Células Matadoras Naturais/patologia , Linfoma de Células T/tratamento farmacológico , Linfoma de Células T/patologia , Neoplasias Nasais/tratamento farmacológico , Neoplasias Nasais/patologia , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Biópsia , Resistencia a Medicamentos Antineoplásicos , Evolução Fatal , Feminino , Humanos , Neoplasias Tonsilares/tratamento farmacológico , Neoplasias Tonsilares/patologia
4.
J Pediatr Hematol Oncol ; 28(12): 837-9, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17164656

RESUMO

High dose of cytosine arabinoside is usually used in treatment of acute myelogenous leukemia. Here we report 1 case of a child who developed neurologic toxicity and rapidly improved after flushing out of cerebral spinal fluid, suggesting it could be treatment in the acute phase of toxicity. Efficacy of this treatment could be explained by reducing cytosine arabinoside metabolites in central nervous system.


Assuntos
Antimetabólitos Antineoplásicos/efeitos adversos , Doenças Cerebelares/induzido quimicamente , Doenças Cerebelares/terapia , Líquido Cefalorraquidiano , Citarabina/efeitos adversos , Leucemia Mieloide Aguda/tratamento farmacológico , Adolescente , Antimetabólitos Antineoplásicos/administração & dosagem , Citarabina/administração & dosagem , Humanos , Leucemia Mieloide Aguda/complicações , Masculino
5.
Eur J Haematol ; 75(1): 54-9, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15946311

RESUMO

The Wiskott-Aldrich syndrome is a rare genetic disorder due to mutations in the WAS gene situated on chromosome X. It is comprised of microthrombocytopenia, eczema and immunodeficiency. However, the phenotypical presentation may vary as to the number and intensity of its manifestations. A milder form of Wiskott-Aldrich syndrome is known as the X-linked thrombocytopenia. We independently found eight individual or familial cases with the V75M substitution (9.76%). This high incidence was partly accounted for by the fact that three cases turned out to be related. The V75M mutation is recurrent, however, due to a CpG island. A genuine homozygous female patient was found. She showed microthrombocytopenia and infections to the same degree as her hemizygous father and brother. The WAS protein was decreased in a comparable fashion in the hemizygotes and the homozygote as well. Its amount was about 10% and 15% of normal in platelets and mononucleated white cells, respectively. In all patients was the picture consistent with XLT.


Assuntos
Substituição de Aminoácidos/genética , Homozigoto , Mutação Puntual , Proteínas/genética , Síndrome de Wiskott-Aldrich/genética , Adulto , Criança , Pré-Escolar , Cromossomos Humanos X , Ilhas de CpG/genética , Eczema/etiologia , Feminino , Humanos , Lactente , Síndrome de Wiskott-Aldrich/complicações , Proteína da Síndrome de Wiskott-Aldrich
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...